Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-15

Clinical Trial Update: Intra-muscular Botulinum Toxin A in Chronic Athletic Pubalgia

View source ↗

Summary

Completed clinical trial evaluating intramuscular botulinum toxin A for chronic athletic pubalgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Athletic Pubalgia | Status: COMPLETED